Updates are available Correction dated 2022-05-16

Article History

Accepted: 24 February 2022

First Online: 20 April 2022

Change Date: 16 May 2022

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s40140-022-00534-0

Declarations

:

: Shashank S. Shettar declares he has no conflict of interest; Kenichi A. Tanaka received fees for serving on the scientific advisory board for HemoSonics and Octapharma; Kofi VanDyck reports research fees from HemoSonics, outside the submitted work for trial of Quantra Qstat cartridge for Quantra Hemostasis Analyzer.

: This article does not contain any studies with human or animal subjects performed by any of the authors.